Figure (Nat07 0000 01)
Natesto Gel, Metered
Product Images NDC 42667-5511
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Natesto (NDC 42667-5511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Acerus Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Nat07 0000 02)
Figure (Nat07 0000 03)
Figure (Nat07 0000 04)
Figure 1 (Nat07 0000 05)
Figure A (Nat07 0000 06)
Figure B (Nat07 0000 07)
Figure C (Nat07 0000 08)
Figure D (Nat07 0000 09)
Figure E (Nat07 0000 10)
Figure F (Nat07 0000 11)
Figure G (Nat07 0000 12)
Figure H (Nat07 0000 13)
Nat07 0000 14
Natesto is a nasal gel that contains 5.5mg of testosterone per actuation delivered through a multi-dose pump with 60 metered doses. The gel is for intranasal use only and comes without child-resistant packaging, so it must be kept out of the reach of children. The active ingredient in this product is testosterone, USP, and it contains Castor Oil, Oleoyl Po-Byolyglycerides, Colloidal Silicon Dioxide, and Cetyl Alcohol. The contents should be stored at 20°-25°C. For further information regarding this product, refer to the enclosed patient information leaflet or visit the website http://www.natesto.com.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
